CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3- (TRIFLUOROMETHYL)BENZYLOXY)-1,2,3, 4-TETRAHYDROCYCLO-PENTA [B]INDOL-3-YL)ACETIC ACID(COMPOUND1) FOR USE IN SIPI RECEPTOR-ASSOCIATED DISORDERS
The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis). |
---|---|
AbstractList | The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis). |
Author | Ma, You-An Montalban, Antonio Garrido Hadd, Mark Allen Blackburn, Anthony C Selvey, Lee Alani Rueter, Jaimie Karyn Carlos, Marlon Castro, Ryan O Shakya, Sagar Raj |
Author_xml | – fullname: Blackburn, Anthony C – fullname: Hadd, Mark Allen – fullname: Shakya, Sagar Raj – fullname: Carlos, Marlon – fullname: Castro, Ryan O – fullname: Ma, You-An – fullname: Rueter, Jaimie Karyn – fullname: Selvey, Lee Alani – fullname: Montalban, Antonio Garrido |
BookMark | eNqNzM1Kw0AUBeAsdOFP3-GCmwRywSTFZjuduTED07nhzgQcRUqRuJK0UN_R19KID-DqnMX5znV2MR_n6Sr70pJCVM5ZT-BQyaP1Sw3KReAOcimwxnyD-Rp10o4H8jE5bBDyKLZzIwvvKPbJFVvyz8nxUyqwKuuyKWGNkaKoPhnhX40LV_CyfbXe8HLz45SmaDUobU2ueTfw6E1VQMcCYyCwHoIdLAhpGiILqhBYWxXJgLGBxZCE2-zy_fBxnlZ_eZPddRR1j9PpuJ_Op8PbNE-f-zHU91VbtQ-bplVV87_VN-OqURg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2018186738A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2018186738A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 09 05:01:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2018186738A13 |
Notes | Application Number: US201615738175 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180705&DB=EPODOC&CC=US&NR=2018186738A1 |
ParticipantIDs | epo_espacenet_US2018186738A1 |
PublicationCentury | 2000 |
PublicationDate | 20180705 |
PublicationDateYYYYMMDD | 2018-07-05 |
PublicationDate_xml | – month: 07 year: 2018 text: 20180705 day: 05 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | Arena Pharmaceuticals, Inc |
RelatedCompanies_xml | – name: Arena Pharmaceuticals, Inc |
Score | 3.1501627 |
Snippet | The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3- (TRIFLUOROMETHYL)BENZYLOXY)-1,2,3, 4-TETRAHYDROCYCLO-PENTA [B]INDOL-3-YL)ACETIC ACID(COMPOUND1) FOR USE IN SIPI RECEPTOR-ASSOCIATED DISORDERS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180705&DB=EPODOC&locale=&CC=US&NR=2018186738A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT9swFLYQTMAb4yIGbLI0VKVSLUiTJulDhVzbWY1SO3Ic1DBN1RJSCQkVNDrtJ_K3Zltl44k3X3TOg4_P8fl8-QzAeRL5TRvYfY1F1FiAkqA6iofIb-K7uo4W7eVPx_YpokkZXs8Gsw3w8PoWxvGE_nHkiMajGuPvKxevn_5vYlF3t_L5or43TY9XqR7Rzhod-4mZwYMOHY9YLqkkHUJGZdERyvVZ7rYgwQYrbdlE2jLts5uxfZfy9HZRSffAh9zoW64-go12uQ92yOvfa_tge7o-8jbFtfc9H4AXoqpCYwO_BYMZwuobF7ZY4ExDmUJPdVEfeTHyQkQqksmcCV1lKEDQ04qnWSmVnDI9qbLumInbKpOzqov8Xr8X9GCINNMKTyqqpJNGVhzD7-MfXFBp1Rg5TJjmBGLCqUfkNJeloH4XGiwJy4JBLmDBcw4VIyzXUiFHG8mxiY-Q8sIgTqaKQ_A1ZZpMkBmR-T8DzMvi7fAFR2Bz-bhsjwFcOC6XYZQMYwPj7JleUvfD-HJhUFzThskncPaeppP3u0_Brq26y7GDM7C5-vW7_WxSgFX9xVnuL7hBpBE |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBalHWvf2m5j63oRbAQHIlbHju08hKFI8qzNkYwsj3ijhNpzYDDS0mbsJ-5vVRLp5alvBx3OeTjSOdKnyycAPiaR33aB3ddYRq0FKAlqoniM_Db-1TTRsju_dGyfIsqq8Ot8NN8Cf-7fwjie0H-OHNFkVGvyfe3q9fXjJhZ1dytvPzW_TdPV51RPaG-Djv3EjOBRj04nrJBUkh4hk6rsCeV0lrstSLDBSjux5ee1i6fvU_su5frppJLugxeF8bdaH4CtbnUIdsn932uH4OVsc-RtxE323b4C_4mqS40N_BYM5girL1xYscS5hjKFnuqjIfJi5IWI1CSXBRO6zlGAoKcVT_NKKjljOqvz_pSJH3Uu53Uf-YPhIBjAEGmmFc5qqqSzRtYcw5_TCy6otG6MHSZMcwIx4dQjclbISlC_Dw2WhFXJIBew5AWHihFWaKmQo43k2NRHSHlpECdT5WvwIWWaZMhEZPHQAYuqfBq-4A3YXl2turcALh2XyzhKxrGBcfZML2mGYXy-NCiu7cLkHTh-ztPR8-ozsJvpWb4wUf32HuxZlbsoOzoG2-ubv92JWQ6sm1PXi3ePdKb- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+L-ARGININE+SALT+OF+%28R%29-2-%287-%284-CYCLOPENTYL-3-+%28TRIFLUOROMETHYL%29BENZYLOXY%29-1%2C2%2C3%2C+4-TETRAHYDROCYCLO-PENTA+%5BB%5DINDOL-3-YL%29ACETIC+ACID%28COMPOUND1%29+FOR+USE+IN+SIPI+RECEPTOR-ASSOCIATED+DISORDERS&rft.inventor=Blackburn%2C+Anthony+C&rft.inventor=Hadd%2C+Mark+Allen&rft.inventor=Shakya%2C+Sagar+Raj&rft.inventor=Carlos%2C+Marlon&rft.inventor=Castro%2C+Ryan+O&rft.inventor=Ma%2C+You-An&rft.inventor=Rueter%2C+Jaimie+Karyn&rft.inventor=Selvey%2C+Lee+Alani&rft.inventor=Montalban%2C+Antonio+Garrido&rft.date=2018-07-05&rft.externalDBID=A1&rft.externalDocID=US2018186738A1 |